Due to recent transactions, Burrill Life Sciences Capital Fund, L.P.'s combined holdings have fallen below 5 per cent of the Company's total shares and voting rights. This decrease may reflect a challenging phase for the fund, possibly indicating a shift in market sentiment towards the Company.